Yahoo News – Reuters
Fri, February 18, 2022, 8:58 A
(Reuters) – Moderna Inc said on Friday it is developing three new vaccines based on the same technology used for its COVID-19 shot, including one for viral infection shingles.
The success of COVID-19 vaccines based on messenger RNA (mRNA) technology from Moderna and rival Pfizer has prompted efforts to use the novel technology in other vaccines and therapeutics targeted at hard-to-treat diseases.
Pfizer is also developing an mRNA-based vaccine for shingles and expects to begin clinical trials in the second half of 2022.
Super Sleuth
